These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35348930)

  • 1. Hypocomplementemia in primary Sjogren's syndrome: association with serological, clinical features, and outcome.
    Lin W; Xin Z; Wang J; Ren X; Liu Y; Yang L; Guo S; Yang Y; Li Y; Cao J; Ning X; Liu M; Su Y; Sun L; Zhang F; Zhang W
    Clin Rheumatol; 2022 Jul; 41(7):2091-2102. PubMed ID: 35348930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for future development of systemic lupus erythematosus in Korean Sjögren's syndrome patients.
    Lee BW; Kwon EJ; Park Y; Lee JJ; Ju JH; Park SH; Kwok SK
    Lupus; 2023 Oct; 32(12):1359-1368. PubMed ID: 37751679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
    Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
    Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proportion of CD161 on CD56
    Zhao P; Yang Y; Song S; Cheng W; Peng C; Chang X; Wu J; Liu C
    Immun Inflamm Dis; 2024 Apr; 12(4):e1244. PubMed ID: 38577997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticentromere antibody positive patients with primary Sjögren's syndrome have distinctive clinical and immunological characteristics.
    Liu Y; Guo L; Lin W; Ning X; Liu M; Cao J; Su Y; Zheng X; Li S; Li F; Ren L; Song G
    Clin Exp Rheumatol; 2023 Dec; 41(12):2371-2378. PubMed ID: 36995331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
    Yang Y; Li Z; Wang L; Zhang F
    Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
    Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
    Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with early-onset primary Sjögren's syndrome have distinctive clinical manifestations and circulating lymphocyte profiles.
    Wei L; Zhifei X; Xiaoran N; Meilu L; Yang L; Yixuan L; Xiuying R; Yashuang S; Jingjing C; Shaoying G; Liu Y; Lijun S; Fengxiao Z; Wen Z
    Rheumatology (Oxford); 2022 Feb; 61(2):597-605. PubMed ID: 33878180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
    Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
    Front Immunol; 2020; 11():594096. PubMed ID: 33193443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year observation of patients with primary Sjögren's syndrome: Initial presenting characteristics and the associated outcomes.
    Tsukamoto M; Suzuki K; Takeuchi T
    Int J Rheum Dis; 2019 May; 22(5):929-933. PubMed ID: 30588773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjögren's syndrome.
    Zhao P; Peng C; Chang X; Cheng W; Yang Y; Shen Y; Sun C; Feng X; Liu C; Wu J
    Clin Rheumatol; 2024 Jan; 43(1):297-306. PubMed ID: 37749409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
    Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of immunological features with clinical manifestations in primary Sjogren's syndrome: a single-center cross-sectional study.
    Relangi HSK; Naidu GSRSNK; Sharma V; Kumar M; Dhir V; Sharma SK; Sharma A; Minz RW; Jain S
    Clin Exp Med; 2022 Nov; 22(4):613-620. PubMed ID: 34762228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Sjögren's syndrome.
    Bowman SJ
    Lupus; 2018 Oct; 27(1_suppl):32-35. PubMed ID: 30452329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
    Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
    Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocomplementemia in Primary Sjogren's Syndrome: A Retrospective Study of 120 Treatment-Naive Chinese Patients.
    Zhou M; Yuan F
    Int J Gen Med; 2022; 15():359-366. PubMed ID: 35035231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
    Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
    Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.